×
About 2,797 results

ALLMedicine™ Hirsutism Center

Research & Reviews  1,277 results

Hyperandrogenic Anovulation: Differential Diagnosis and Evaluation.
https://doi.org/10.1016/j.ecl.2020.12.003
Endocrinology and Metabolism Clinics of North America; Wierman ME

Feb 1st, 2021 - Hyperandrogenic anovulation refers to the constellation of disorders that present in women with irregular menses, hirsutism and/or acne across the lifespan. Understanding the clinical signs and symptoms of each diagnosis in the differential and la...

Fertility Issues in Polycystic Ovarian Disease: A Systematic Approach.
https://doi.org/10.1016/j.ecl.2020.10.004
Endocrinology and Metabolism Clinics of North America; Rushing JS, Santoro N

Feb 1st, 2021 - The triad of hirsutism, amenorrhea, and enlarged polycystic ovaries first was described in 1935 and later become known as polycystic ovarian syndrome (PCOS). Women with PCOS are more likely to have cardiometabolic challenges that also have an indi...

Menstrual Disorders and Androgen-Related Traits in Young Women with Type 1 Diabetes Mel...
https://doi.org/10.4158/EP-2020-0153
Endocrine Practice : Official Journal of the American Col... Paschou SA, Vryonidou A et. al.

Jan 20th, 2021 - To investigate possible causes of menstrual disorders and androgen-related traits in young women with type 1 diabetes mellitus (T1DM). Fifty-three women with T1DM (duration 8.0±5.6 years), 41 women with (polycystic ovary syndrome) PCOS, and 51 con...

Bilateral microscopic Leydig cell ovarian tumors in the postmenopausal woman.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757481
BMJ Case Reports; Langevin TL, Maynard K et. al.

Dec 29th, 2020 - A 64-year-old postmenopausal female patient presented with approximately 5 years of intermittent spotting, progressive hirsutism and significantly increased libido and clitoral hypersensitivity with spontaneous orgasms multiple times a day beginni...

Clinical Obstetrics & Gynecology: Polycystic Ovary Disease Ethnicity, Diversity, and Ps...
https://doi.org/10.1097/GRF.0000000000000582
Clinical Obstetrics and Gynecology; Burgart JM

Dec 11th, 2020 - Polycystic ovary disease is a heterogenous disorder that presents differently in each individual. Some of this variation is due to racial and ethnic differences, which has been shown to affect hirsutism scores, metabolic comorbidities, cardiovascu...

see more →

Guidelines  15 results

Screening and Management of the Hyperandrogenic Adolescent
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Screening-and-Management-of-the-Hyperandrogenic-Adolescent

Sep 23rd, 2019 - Although androgen excess can manifest in many ways, the most common and recognizable symptoms are hirsutism and acne. Reports of hirsutism and acne should be taken seriously because of their possible association with medical disorders, their subst...

Hirsutism in Women
https://www.aafp.org/afp/2019/0801/p168.html

Jul 31st, 2019 - Hirsutism is the excessive growth of terminal hair in a typical male pattern in a female. It is often a sign of excessive androgen levels. Although many conditions can lead to hirsutism, polycystic ovary syndrome and idiopathic hyperandrogenism ac...

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical ...
https://academic.oup.com/jcem/article/103/4/1233/4924418
Kathryn A. Martin

Mar 31st, 2018 - We suggest testing for elevated androgen levels in all women with an abnormal hirsutism score. We suggest against testing for elevated androgen levels in eumenorrheic women with unwanted local hair growth (i.

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clin...
https://doi.org/10.1210/jc.2018-00241
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Anderson RR et. al.

Mar 9th, 2018 - To update the "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2008. The participants include an Endocrine Society-appointed task force of seven...

No. 350-Hirsutism: Evaluation and Treatment.
https://doi.org/10.1016/j.jogc.2017.05.022
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Liu K, Motan T et. al.

Oct 30th, 2017 - To review the etiology, evaluation, and treatment of hirsutism. A thorough history and physical examination plus selected laboratory evaluations will confirm the diagnosis and direct treatment. Pharmacologic interventions can suppress ovarian or a...

see more →

Clinicaltrials.gov  1,371 results

Increased Risk of Meningioma With Cyproterone Acetate Use
https://www.medscape.com/viewarticle/945218

Feb 2nd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...

Hyperandrogenic Anovulation: Differential Diagnosis and Evaluation.
https://doi.org/10.1016/j.ecl.2020.12.003
Endocrinology and Metabolism Clinics of North America; Wierman ME

Feb 1st, 2021 - Hyperandrogenic anovulation refers to the constellation of disorders that present in women with irregular menses, hirsutism and/or acne across the lifespan. Understanding the clinical signs and symptoms of each diagnosis in the differential and la...

Fertility Issues in Polycystic Ovarian Disease: A Systematic Approach.
https://doi.org/10.1016/j.ecl.2020.10.004
Endocrinology and Metabolism Clinics of North America; Rushing JS, Santoro N

Feb 1st, 2021 - The triad of hirsutism, amenorrhea, and enlarged polycystic ovaries first was described in 1935 and later become known as polycystic ovarian syndrome (PCOS). Women with PCOS are more likely to have cardiometabolic challenges that also have an indi...

Menstrual Disorders and Androgen-Related Traits in Young Women with Type 1 Diabetes Mel...
https://doi.org/10.4158/EP-2020-0153
Endocrine Practice : Official Journal of the American Col... Paschou SA, Vryonidou A et. al.

Jan 20th, 2021 - To investigate possible causes of menstrual disorders and androgen-related traits in young women with type 1 diabetes mellitus (T1DM). Fifty-three women with T1DM (duration 8.0±5.6 years), 41 women with (polycystic ovary syndrome) PCOS, and 51 con...

Bilateral microscopic Leydig cell ovarian tumors in the postmenopausal woman.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757481
BMJ Case Reports; Langevin TL, Maynard K et. al.

Dec 29th, 2020 - A 64-year-old postmenopausal female patient presented with approximately 5 years of intermittent spotting, progressive hirsutism and significantly increased libido and clitoral hypersensitivity with spontaneous orgasms multiple times a day beginni...

see more →

News  117 results

Increased Risk of Meningioma With Cyproterone Acetate Use
https://www.medscape.com/viewarticle/945218

Feb 2nd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...

Metformin Not Better Than Oral Contraceptive for Treating PCOS-Related Hirsutism
https://www.medscape.com/viewarticle/936850

Sep 7th, 2020 - NEW YORK (Reuters Health) - Metformin monotherapy might be less effective than oral contraceptive pills (OCPs) for treating hirsutism in women with polycystic ovary syndrome (PCOS), according to a new Cochrane review. In fact, "OCP alone or metfor...

GPs Need Better Education on All Symptoms of PCOS, Say Patients
https://www.medscape.com/viewarticle/927116

Mar 18th, 2020 - Women who have polycystic ovary syndrome (PCOS) often feel their general practitioners (GPs) trivialize the condition as only a fertility problem and do not discuss any of the other long-term health consequences, new results from a UK survey revea...

EU Restricts High-Dose Cyproterone Because of Meningioma Risk
https://www.medscape.com/viewarticle/925271

Feb 13th, 2020 - Cyproterone products with daily doses of 10 mg or more should be restricted because of a risk of developing meningioma, says the safety committee of the European Medicines Agency. Products containing cyproterone 10 mg daily or more should be used ...

Screening and Management of the Hyperandrogenic Adolescent
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Adolescent-Health-Care/Screening-and-Management-of-the-Hyperandrogenic-Adolescent

Sep 23rd, 2019 - Although androgen excess can manifest in many ways, the most common and recognizable symptoms are hirsutism and acne. Reports of hirsutism and acne should be taken seriously because of their possible association with medical disorders, their subst...

see more →

Patient Education  17 results see all →